Product category:
Clinical chemistry analysis
News Release from: Randox Laboratories | Subject: Drugs of Abuse array
Edited by the Laboratorytalk Editorial
Team on 12 September 2005
Drugs of abuse test wins FDA clearance
Biochip allows detection of amphetamine, methamphetamine, cocaine, barbiturates, cannabinoids, opiates, methadone, benzodiazepines, lorazepam, phencyclidine and creatinine from a single urine sample
Randox has received FDA clearance for its Drugs of Abuse array for use on the evidence analyser The multi-analyte biochip allows the simultaneous detection of amphetamine, methamphetamine, cocaine, barbiturates, cannabinoids, opiates, methadone, benzodiazepines, lorazepam, phencyclidine and creatinine from a single urine sample
The company says the evidence analyser is at the forefront of biochip array technology, offering the latest technological advances in clinical analysis. Request a free brochure from Randox Laboratories ...
• Randox Laboratories: contact details and other news
• Email this article to a colleague
• Register for the free Laboratorytalk email newsletter
• Laboratorytalk Home Page
Search the Pro-Talk network of sites
